FDA Approves OTEZLA (apremilast) for the Treatment of Oral Ulcers Associated with Behçet’s Disease Read more
Celltrion and Nan Fung Group to establish Vcell Healthcare Limited to Develop and Commercialize Biosimilars in China Read more
MilliporeSigma and Broad Institute Announce CRISPR License Framework to Encourage Innovation Read more
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi Therapeutics For Complement-Mediated Diseases Read more
INMARK results suggest prompt treatment of IPF with antifibrotics to slow disease progression Read more
Astellas and Frequency Therapeutics Enter into License Agreement for FX-322, a Regenerative Treatment Candidate for Hearing Loss Read more